XML 25 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2017     20,520,856            
Beginning balance at Dec. 31, 2017 $ 463,209 $ 0 $ 21 $ 84,866 $ 376,119 $ 2,203 $ 2,203 $ (2,203) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 38,767       38,767        
Unrealized income (loss) on investment, net of taxes 0                
Adjustment to pension benefit plans, net of taxes 0                
Share-based compensation 2,020     2,117 (97)        
Issuance of restricted and deferred stock units (in shares)     95,053            
Issuance of restricted and deferred stock units $ (4,057)     (4,057)          
Employee stock purchase plan (in shares) 25,907   25,907            
Employee stock purchase plan $ 1,371     1,371          
Common stock issued (in shares)     7,762,500            
Common stock issued 411,076   $ 7 411,069          
Dividends paid (23,074)       (23,074)        
Ending balance (in shares) at Dec. 31, 2018     28,404,316            
Ending balance at Dec. 31, 2018 889,312 $ 97 $ 28 495,366 393,918 $ 97 0   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 23,627       23,403       224
Distribution to noncontrolling interest (224)               (224)
Unrealized income (loss) on investment, net of taxes 117           117    
Adjustment to pension benefit plans, net of taxes 9           9    
Share-based compensation 3,313     3,406 (93)        
Share-based compensation related to business combination 6,384     6,384          
Issuance of restricted and deferred stock units (in shares)     21,909            
Issuance of restricted and deferred stock units $ (110)     (110)          
Employee stock purchase plan (in shares) 30,255   30,283            
Employee stock purchase plan $ 1,603     1,603          
Common stock issuance cost (10)     (10)          
Dividends paid $ (34,134)       (34,134)        
Ending balance (in shares) at Dec. 31, 2019 28,456,508   28,456,508            
Ending balance at Dec. 31, 2019 $ 889,984   $ 28 506,639 383,191   126   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 61,515       61,515        
Unrealized income (loss) on investment, net of taxes (310)           (310)    
Adjustment to pension benefit plans, net of taxes (880)           (880)    
Share-based compensation 3,393     3,553 (160)        
Issuance of restricted and deferred stock units (in shares)     68,347            
Issuance of restricted and deferred stock units $ (1,863)   $ 1 (1,864)          
Employee stock purchase plan (in shares) 31,750   31,750            
Employee stock purchase plan $ 1,830     1,830          
Dividends paid $ (36,509)       (36,509)        
Ending balance (in shares) at Dec. 31, 2020 28,556,605   28,556,605            
Ending balance at Dec. 31, 2020 $ 917,160   $ 29 $ 510,158 $ 408,037   $ (1,064)   $ 0